T. Rowe Price Associates’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $665K | Sell |
|
|||||
|
2025
Q1 | $6.49M | Buy |
|
|||||
|
2024
Q4 | $776K | Buy |
|
|||||
|
2024
Q3 | $636K | Buy |
|
|||||
|
2024
Q2 | $416K | Buy |
|
|||||
|
2024
Q1 | $300K | Sell |
|
|||||
|
2023
Q4 | $1.38M | Buy |
|
|||||
|
2023
Q3 | $722K | Buy |
|
|||||
|
2023
Q2 | $968K | Buy |
|
|||||
|
2023
Q1 | $819K | Sell |
|
|||||
|
2022
Q4 | $2.31M | Buy |
|
|||||
|
2022
Q3 | $2.52M | Sell |
|
|||||
|
2022
Q2 | $2.78M | Sell |
|
|||||
|
2022
Q1 | $3.39M | Buy |
|